FDA official logo
GSRS logo
PFDA official logo

IPILIMUMAB

  • UNII: 6T8C155666
  • Preferred Substance Name: IPILIMUMAB

  • 477202-00-9
  • BMS734016
  • BMS-734016
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN .KAPPA.-CHAIN, DIMER
  • IPILIMUMAB [EMA EPAR]
  • IPILIMUMAB [INN]
  • IPILIMUMAB [MART.]
  • IPILIMUMAB [MI]
  • IPILIMUMAB [PURPLE BOOK, CDER]
  • IPILIMUMAB [USAN]
  • IPILIMUMAB [VANDF]
  • IPILIMUMAB [WHO-DD]
  • MDX010
  • MDX-010
  • MDX-101
  • MDX-CTLA-4
  • YERVOY

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.